During the past decade, North Carolina Neuropsychiatry, PA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Carolina Neuropsychiatry, PA" #1 sponsor was "Abbott" with 1 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "Noven Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Carolina Neuropsychiatry, PA" #1 collaborator was "Noven Pharmaceuticals, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "North Carolina Neuropsychiatry, PA" are "Major Depressive Disorder" (2 trials), "Alzheimer's Disease" (1 trials), "Attention Deficit Disorder With Hyperactivity" (1 trials), "Bipolar I Disorder" (1 trials) and "Generalized Anxiety Disorder" (1 trials). Many other conditions were trialed in "North Carolina Neuropsychiatry, PA" in a lesser frequency.

Most popular intervention types in "North Carolina Neuropsychiatry, PA" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Aricept" (1 trials), "Divalproex Sodium (Depakote ER)" (1 trials), "Escitalopram" (1 trials), "Matching placebo" (1 trials) and "Methylphenidate Transdermal System" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Carolina Neuropsychiatry, PA" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "North Carolina Neuropsychiatry, PA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in North Carolina Neuropsychiatry, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Carolina Neuropsychiatry, PA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".